Rosolutamide

N/A

Report date: 2025/05/15 14:16:45
NME

Base Information

Drug NameRosolutamide
Drug Alias NameAJ-201JM17ALZ002 DSASC-JM-17ALZ-002 +[9] 
ClassificationSmall molecules
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsBulbo-Spinal Atrophy, X-Linked
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllianz Pharmascience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvenue Therapeutics IncAnnJi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBulbo-Spinal Atrophy, X-Linked
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A